Factors that may explain observed associations between trivalent influenza vaccination and gastrointestinal illness in young children
- PMID: 23831326
- DOI: 10.1016/j.vaccine.2013.06.051
Factors that may explain observed associations between trivalent influenza vaccination and gastrointestinal illness in young children
Abstract
Background: Previously published studies reported an increased risk of gastrointestinal illness in the 14 days following trivalent influenza vaccination (TIV) in young children. While gastrointestinal illness may be a true adverse effect of TIV, other factors may influence this observed association, such as seasonal illness patterns and children being exposed to gastrointestinal pathogens at medical visits. The objective of this study was to examine factors influencing the association between TIV and gastrointestinal illness. Specifically, using data from a previous influenza vaccine safety study, we examined the association between medical encounters without TIV and gastrointestinal illness.
Methods: Using electronic health record (EHR) data from 6 managed care organizations (MCOs), we identified medically attended gastrointestinal illness cases among children 24-59 months in the 2002-2006 influenza seasons. We matched each case to four controls on sex, birthdate (month/year), MCO, influenza season, and presence of a chronic condition. We then looked 1-14 days prior to the index date (gastrointestinal illness diagnosis date) to determine whether the child had a medical encounter. We excluded previous medical encounters with gastrointestinal-related diagnoses or TIV. Conditional logistic regression was used to calculate odds ratios and 95% confidence intervals.
Results: We identified 2062 gastrointestinal illness cases and matched them to 8248 controls. We observed increased odds of gastrointestinal illness within 14 days after a medical encounter (odds ratio=1.9; 95% confidence interval [CI]: 1.7-2.2) among children without chronic conditions. Among children with chronic conditions, the odds ratio was 3.9 (95% CI: 2.5-6.2).
Conclusions: We demonstrated that another exposure related to vaccination, medical visits, is also associated with increased odds for gastrointestinal illness. This study highlights challenges of interpreting results from observational vaccine safety studies when there are co-occurring exposures, and the importance of investigating confounding in EHR data, which are an essential resource for vaccine safety research.
Keywords: CI; ED; Electronic medical records; GI; Gastrointestinal illness; ICD-9; Influenza vaccination; International Classification of Diseases – 9th revision; MCO; Observational research; SD; TIV; VSD; Vaccine Safety Datalink; confidence interval; emergency department; gastrointestinal; mOR; managed care organization; matched odds ratio; standard deviation; trivalent influenza vaccination.
Copyright © 2013 Elsevier Ltd. All rights reserved.
Similar articles
-
Guillain-Barré Syndrome, Influenza Vaccination, and Antecedent Respiratory and Gastrointestinal Infections: A Case-Centered Analysis in the Vaccine Safety Datalink, 2009-2011.PLoS One. 2013 Jun 26;8(6):e67185. doi: 10.1371/journal.pone.0067185. Print 2013. PLoS One. 2013. PMID: 23840621 Free PMC article.
-
Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011.Vaccine. 2012 Mar 2;30(11):2024-31. doi: 10.1016/j.vaccine.2012.01.027. Vaccine. 2012. PMID: 22361304
-
Safety of trivalent inactivated influenza vaccine in children aged 24 to 59 months in the vaccine safety datalink.Arch Pediatr Adolesc Med. 2011 Aug;165(8):749-55. doi: 10.1001/archpediatrics.2011.112. Arch Pediatr Adolesc Med. 2011. PMID: 21810637
-
Safety of trivalent inactivated influenza vaccine in children 6 to 23 months old.JAMA. 2006 Oct 25;296(16):1990-7. doi: 10.1001/jama.296.16.1990. JAMA. 2006. PMID: 17062862
-
Safety of the trivalent inactivated influenza vaccine among children: a population-based study.Arch Pediatr Adolesc Med. 2004 Nov;158(11):1031-6. doi: 10.1001/archpedi.158.11.1031. Arch Pediatr Adolesc Med. 2004. PMID: 15520339
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical